Found: 2
Select item for more details and to access through your institution.
Combined OX40L and mTOR blockade controls effector T cell activation while preserving T<sub>reg</sub> reconstitution after transplant.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 408, p. 1, doi. 10.1126/scitranslmed.aan3085
- By:
- Publication type:
- Article
CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates.
- Published in:
- 2018
- By:
- Publication type:
- journal article